Data search
Results for MligTC455_13505
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_13505 | 132 | 2.74 | Mlig455_027944 | Neo: - Age: Up-Down-Down |
KCND2 | Mlig455_027944 {REF} {Length: 4404} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=127.7]; BTB/POZ domain [PF02214.24, score=91.1]; Ion channel [PF07885.18, score=49.3]; Shal-type voltage-gated potassium channels, N-terminal [PF11601.10, score=48.9]; Domain of unknown function (DUF3399) [PF11879.10, score=43.6]; BTB/POZ domain [PF16017.7, score=28.0]} {Human: ENSG00000184408, KCND2, potassium voltage-gated channel subfamily D member 2, [RH, Score=719, Expect=0.0]; ENSG00000171385, KCND3, potassium voltage-gated channel subfamily D member 3, [RH, Score=711, Expect=0.0]; ENSG00000102057, KCND1, potassium voltage-gated channel subfamily D member 1, [RH, Score=691, Expect=0.0]} {Mouse: ENSMUSG00000060882, Kcnd2, potassium voltage-gated channel, Shal-related family, member 2, [RH, Score=716, Expect=0.0]; ENSMUSG00000040896, Kcnd3, potassium voltage-gated channel, Shal-related family, member 3, [RH, Score=712, Expect=0.0]; ENSMUSG00000009731, Kcnd1, potassium voltage-gated channel, Shal-related family, member 1, [RH, Score=694, Expect=0.0]} {Dmel: FBgn0005564, Shal, Shaker cognate l, [RH, Score=747, Expect=0.0]} {Celegans: WBGene00022240, shl-1, SHaL family of potassium channels, [RH, Score=712, Expect=0.0]} {Smed: dd_Smed_v6_15876_0_1, dd_Smed_v6_15876_0_1, [RH, Score=716, Expect=0.0]} {RNA1509_23965} {RNA1310_7319} {RNA815_9248} |
Cumulative graph for MligTC455_13505
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -4.387 | 2.282 | 0.41951 | 1.00000 | |
| RegionR2 | 2.056 | 2.282 | 0.09150 | 0.37101 | |
| RegionR3 | 0.979 | 2.282 | 0.34517 | 0.88041 | |
| RegionR4 | 1.437 | 2.282 | 0.24717 | 0.54569 | |
| RegionR5 | 1.211 | 2.282 | 0.18879 | 0.47146 | |
| RegionR6 | 0.86 | 2.282 | 0.43304 | 0.99563 | |
| RegionR7 | -1.415 | 2.282 | 0.99613 | 1.00000 | |
| RegionR8 | -0.741 | 2.282 | 0.97768 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 1.2 | 2.282 | 0.99984 | 1.00000 | |
| RegenerationR2 | -0.487 | 2.282 | 0.50002 | 0.87170 | |
| RegenerationR3 | 0.256 | 2.282 | 0.78341 | 0.97669 | |
| RegenerationR4 | 0.371 | 2.282 | 0.72779 | 0.96403 | |
| RegenerationR5 | 0.107 | 2.282 | 0.90030 | 1.00000 | |
| RegenerationR6 | 0.249 | 2.282 | 0.79271 | 0.97360 | |
| RegenerationBL | 3.288 | 2.282 | 0.00118 | 0.02558 | |
| RegenerationTP | 1.201 | 2.282 | 0.41740 | 0.84215 |
Genes with expression patterns similar to MligTC455_13505
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_13505 | 132 | 2.74 | Mlig455_027944 | Neo: - Age: Up-Down-Down |
KCND2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_027944 {REF} {Length: 4404} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=127.7]; BTB/POZ domain [PF02214.24, score=91.1]; Ion channel [PF07885.18, score=49.3]; Shal-type voltage-gated potassium channels, N-terminal [PF11601.10, score=48.9]; Domain of unknown function (DUF3399) [PF11879.10, score=43.6]; BTB/POZ domain [PF16017.7, score=28.0]} {Human: ENSG00000184408, KCND2, potassium voltage-gated channel subfamily D member 2, [RH, Score=719, Expect=0.0]; ENSG00000171385, KCND3, potassium voltage-gated channel subfamily D member 3, [RH, Score=711, Expect=0.0]; ENSG00000102057, KCND1, potassium voltage-gated channel subfamily D member 1, [RH, Score=691, Expect=0.0]} {Mouse: ENSMUSG00000060882, Kcnd2, potassium voltage-gated channel, Shal-related family, member 2, [RH, Score=716, Expect=0.0]; ENSMUSG00000040896, Kcnd3, potassium voltage-gated channel, Shal-related family, member 3, [RH, Score=712, Expect=0.0]; ENSMUSG00000009731, Kcnd1, potassium voltage-gated channel, Shal-related family, member 1, [RH, Score=694, Expect=0.0]} {Dmel: FBgn0005564, Shal, Shaker cognate l, [RH, Score=747, Expect=0.0]} {Celegans: WBGene00022240, shl-1, SHaL family of potassium channels, [RH, Score=712, Expect=0.0]} {Smed: dd_Smed_v6_15876_0_1, dd_Smed_v6_15876_0_1, [RH, Score=716, Expect=0.0]} {RNA1509_23965} {RNA1310_7319} {RNA815_9248} |
| 2. | MligTC455_13506 | 189 | 3.95 | Mlig455_027975 | Neo: - Age: - |
3.626 | 0.886 | 0.843 | 0.929 | 0.968 | - | - | Mlig455_027975 {REF} {Length: 368} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_37868} {RNA815_46374} | |
| 3. | MligTC455_37749 | 41 | 0.86 | Mlig455_041848 | Neo: - Age: Up-Down-Up |
1.875 | - | - | 0.959 | - | 0.916 | - | Mlig455_041848 {REF} {Length: 3268} {Smed: dd_Smed_v6_13730_0_1, dd_Smed_v6_13730_0_1, [Score=168, Expect=4e-43]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} | |
| 4. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
1.823 | - | - | 0.951 | 0.872 | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
| 5. | MligTC455_18171 | 108 | 2.25 | Mlig455_034306, Mlig455_067304, Mlig455_067320 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.816/0.02161 Regeneration-upregulated BL: 6.953 Regeneration-enriched BL: 6.953 |
1.794 | - | - | 0.977 | 0.817 | - | - | Mlig455_034306 {REF} {Length: 840} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067304 {REF} {Length: 733} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067320 {REF} {Length: 454} {RNA1310_58083} {RNA815_58789} |
|
| 6. | MligTC455_35436 | 244 | 5.09 | Mlig455_066072 | Neo: - Age: - Region-enriched R2: 2.834/0.01983 |
GLRA2 | 1.793 | - | - | 0.980 | - | - | 0.813 | Mlig455_066072 {REF} {Length: 4141} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.1]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=249, Expect=7e-77]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=246, Expect=1e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=241, Expect=9e-74]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=240, Expect=2e-73]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=237, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=246, Expect=4e-76]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=257, Expect=5e-80]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=448, Expect=7e-155]} {RNA1509_35986} {RNA1310_23400, RNA1509_35986} {RNA1509_35986, RNA815_18122} |
| 7. | MligTC455_32326 | 37 | 0.77 | Mlig455_001525 | Neo: - Age: - |
TRIM9 | 1.773 | - | - | 0.966 | - | - | 0.807 | Mlig455_001525 {REF} {Length: 3229} {Pfam: SPRY domain [PF00622.30, score=48.4]; B-box zinc finger [PF00643.26, score=33.5]; zinc finger of C3HC4-type, RING [PF15227.8, score=28.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=28.1]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=25.4]; RING-type zinc-finger [PF13445.8, score=24.0]; Fibronectin type III domain [PF00041.23, score=23.3]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=21.4]; Prokaryotic RING finger family 4 [PF14447.8, score=18.8]} {Human: ENSG00000100505, TRIM9, tripartite motif containing 9, [Score=475, Expect=2e-158]} {Mouse: ENSMUSG00000021071, Trim9, tripartite motif-containing 9, [Score=474, Expect=3e-158]} {Dmel: FBgn0051721, Trim9, Tripartite motif containing 9, [Score=444, Expect=1e-146]} {Celegans: WBGene00016539, madd-2, [Score=409, Expect=1e-132]} {Smed: dd_Smed_v6_8386_0_1, dd_Smed_v6_8386_0_1, [Score=524, Expect=1e-177]} {RNA1509_37451} {RNA1310_8634.1} {RNA815_9833} |
| 8. | MligTC455_44068 | 47 | 0.99 | Mlig455_063671 | Neo: - Age: - |
THRA | 1.766 | - | - | - | 0.950 | 0.816 | - | Mlig455_063671 {REF} {Length: 4986} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=106.0]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=63.6]} {Human: ENSG00000126351, THRA, thyroid hormone receptor alpha, [Score=170, Expect=4e-45]} {Mouse: ENSMUSG00000058756, Thra, thyroid hormone receptor alpha, [Score=173, Expect=5e-46]} {Dmel: FBgn0000546, EcR, Ecdysone receptor, [Score=172, Expect=4e-44]} {Celegans: WBGene00003613, nhr-14, Nuclear hormone receptor family member nhr-14, [Score=110, Expect=2e-25]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=194, Expect=7e-52]} {RNA1509_27629} {RNA1310_74061} {RNA815_54074} |
| 9. | MligTC455_40239 | 433 | 9.02 | Mlig455_034356, Mlig455_034420, Mlig455_034464 | Neo: Irradiation Age: Up-Down-Down Region-specific R4: 2.722 Region-enriched R4: 2.901/0.00089 |
PNPO | 1.761 | - | - | - | 0.787 | 0.974 | - | Mlig455_034356 {REF} {Length: 1978} {TRANSSPLICED} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=53.2]; Pyridoxamine 5'-phosphate oxidase like [PF16242.7, score=32.9]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=72.4, Expect=1e-14]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [Score=67.0, Expect=8e-13]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [Score=57.8, Expect=6e-10]} {RNA1509_36121} {RNA1310_23054.1} {RNA815_20727} Mlig455_034420 {REF} {Length: 2138} {TRANSSPLICED} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=53.2]; Pyridoxamine 5'-phosphate oxidase like [PF16242.7, score=32.9]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=72.0, Expect=2e-14]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [Score=66.2, Expect=1e-12]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [Score=57.4, Expect=6e-10]} {RNA1509_36121} {RNA1310_23054.1} {RNA815_20727} Mlig455_034464 {REF} {Length: 2369} {TRANSSPLICED} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=53.2]; Pyridoxamine 5'-phosphate oxidase like [PF16242.7, score=32.9]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=72.0, Expect=2e-14]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [Score=66.2, Expect=1e-12]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [Score=57.4, Expect=6e-10]} {RNA1509_36121} {RNA1310_23054.1} {RNA815_20727} |
| 10. | MligTC455_11977 | 204 | 4.25 | Mlig455_043564, Mlig455_063896, Mlig455_064152 | Neo: - Age: logFC(26M/2M)=0.461 Region-enriched R8: 3.187/0.02458 |
1.753 | - | - | 0.989 | - | - | 0.764 | Mlig455_043564 {REF} {Length: 1815} {RNA1509_29097} {RNA1310_7101.2} {RNA815_7291.1} Mlig455_063896 {REF} {Length: 1922} {TRANSSPLICED} {Pfam: Cornifin (SPRR) family [PF02389.17, score=19.5]} {RNA1509_29097} {RNA1310_7101.2} {RNA815_7291.1} Mlig455_064152 {REF} {Length: 1641} {TRANSSPLICED} {RNA1509_29097} {RNA1310_7340} {RNA815_7291.1} |
|
| 11. | MligTC455_40405 | 83 | 1.72 | Mlig455_015672 | Neo: - Age: - Region-enriched R2: 4.956/0.00100 |
CHRNA9 | 1.745 | - | - | 0.986 | - | - | 0.759 | Mlig455_015672 {REF} {Length: 3935} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=204, Expect=4e-59]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=202, Expect=2e-58]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=201, Expect=5e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=200, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=1e-56]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=197, Expect=3e-55]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=196, Expect=1e-55]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=194, Expect=5e-55]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=8e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=205, Expect=4e-59]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=201, Expect=3e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=201, Expect=4e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=191, Expect=8e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=446, Expect=1e-151]} {RNA1509_18288} {RNA1310_3728} {RNA815_3826.1} |
| 12. | MligTC455_32808 | 28 | 0.59 | Mlig455_035028, Mlig455_053438 | Neo: - Age: - Region-enriched R2: 7.450/0.04766 |
WSCD2 | 1.741 | - | - | 0.982 | - | - | 0.759 | Mlig455_035028 {REF} {Length: 1155} {Pfam: WSC domain [PF01822.21, score=54.3]; PAN domain [PF00024.28, score=21.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=3e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=8e-06]} {RNA1310_133946} Mlig455_053438 {REF} {Length: 1155} {Pfam: WSC domain [PF01822.21, score=54.3]; PAN domain [PF00024.28, score=21.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=3e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=8e-06]} {RNA1310_133946} |
| 13. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
1.737 | - | - | 0.953 | - | - | 0.784 | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
| 14. | MligTC455_25949 | 221 | 4.59 | Mlig455_001818, Mlig455_025869, Mlig455_025960, Mlig455_056965, Mlig455_058910 | Neo: Int S/G2/M Age: - |
1.729 | - | - | 0.779 | - | 0.950 | - | Mlig455_001818 {REF} {Length: 189} {NoTransDecoderORF} {RNA1310_44928} {RNA815_23085.2} Mlig455_025869 {REF} {Length: 790} {RNA1310_68154} {RNA815_23085.1} Mlig455_025960 {REF} {Length: 860} {RNA1310_68154} {RNA815_23085.1} Mlig455_056965 {REF} {Length: 553} {NoTransDecoderORF} {RNA1509_18737} {RNA1310_24175.1} {RNA815_21371.1} Mlig455_058910 {REF} {Length: 429} {TRANSSPLICED} {RNA1310_44928} {RNA815_23085.2} |
|
| 15. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.72 | - | - | 0.977 | - | - | 0.743 | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
| 16. | MligTC455_44914 | 126 | 2.63 | Mlig455_002960 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.561/0.00718 |
1.719 | - | - | 0.965 | 0.754 | - | - | Mlig455_002960 {REF} {Length: 2090} {RNA1310_31218} {RNA815_36991} | |
| 17. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 1.716 | - | - | 0.960 | - | - | 0.756 | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
| 18. | MligTC455_39829 | 112 | 2.34 | Mlig455_015928 | Neo: - |
SVOP | 1.714 | - | - | - | 0.747 | 0.967 | - | Mlig455_015928 {REF} {Length: 4798} {Pfam: Sugar (and other) transporter [PF00083.26, score=137.1]; Major Facilitator Superfamily [PF07690.18, score=130.4]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=134, Expect=3e-32]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=120, Expect=8e-28]} {Dmel: FBgn0034956, CG4324, [Score=127, Expect=1e-30]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=138, Expect=3e-34]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=178, Expect=4e-48]} {RNA1509_47157} {RNA1310_47802} {RNA815_44733} |
| 19. | MligTC455_33091 | 131 | 2.74 | Mlig455_022350 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.067 Region-enriched R2: 5.543/0.01732 |
GIMAP4 | 1.713 | - | - | 0.952 | - | - | 0.761 | Mlig455_022350 {REF} {Length: 1730} {Pfam: AIG1 family [PF04548.18, score=119.5]; 50S ribosome-binding GTPase [PF01926.25, score=34.5]; Dynamin family [PF00350.25, score=25.0]} {Human: ENSG00000133574, GIMAP4, GTPase, IMAP family member 4, [RH, Score=95.5, Expect=5e-22]} {Mouse: ENSMUSG00000054435, Gimap4, GTPase, IMAP family member 4, [RH, Score=91.7, Expect=2e-21]} {RNA1509_22161} {RNA1310_33853} {RNA815_17084} |
| 20. | MligTC455_21764 | 52 | 1.08 | Mlig455_031141 | Neo: - Age: - Region-enriched R2: 7.444/0.02053 |
1.711 | - | - | 0.975 | - | - | 0.736 | Mlig455_031141 {REF} {Length: 3213} {NoTransDecoderORF} {RNA1310_23238} {RNA815_41806} | |
| 21. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1.702 | - | - | 0.975 | - | - | 0.727 | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
| 22. | MligTC455_17684 | 157 | 3.26 | Mlig455_041455 | Neo: Irradiation Age: Up-Down-Down |
ASPG | 1.698 | 0.735 | - | 0.963 | - | - | - | Mlig455_041455 {REF} {Length: 5938} {TRANSSPLICED} {Pfam: Asparaginase, N-terminal [PF00710.22, score=202.1]; Glutaminase/Asparaginase C-terminal domain [PF17763.3, score=84.6]; Ankyrin repeats (many copies) [PF13857.8, score=64.3]; Ankyrin repeats (3 copies) [PF12796.9, score=59.0]; Ankyrin repeats (many copies) [PF13637.8, score=54.0]; Ankyrin repeat [PF13606.8, score=43.8]; Ankyrin repeat [PF00023.32, score=35.8]} {Human: ENSG00000166183, ASPG, asparaginase, [Score=346, Expect=7e-110]} {Mouse: ENSMUSG00000037686, Aspg, asparaginase, [Score=340, Expect=9e-108]} {Dmel: FBgn0029689, CG6428, [RH, Score=439, Expect=2e-145]} {Celegans: WBGene00007756, C27A7.5, [Score=412, Expect=1e-134]} {Smed: dd_Smed_v6_7816_0_1, dd_Smed_v6_7816_0_1, [RH, Score=426, Expect=7e-140]} {RNA1509_11582, RNA1509_16816, RNA1509_8667} {RNA1310_8678, RNA1509_16816, RNA1509_8667} {RNA1509_16816, RNA1509_8667, RNA815_6302} |
| 23. | MligTC455_16847 | 1240 | 25.83 | Mlig455_051898, Mlig455_053146 | Neo: - Age: Down-Up-Down Region-specific R2: 5.478 Region-enriched R2: 5.690/0.00000 |
PRSS33 | 1.69 | - | - | 0.974 | - | - | 0.716 | Mlig455_051898 {REF} {Length: 1360} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_29335} {RNA1310_23561} {RNA815_9840} Mlig455_053146 {REF} {Length: 1448} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_26566, RNA1509_29335} {RNA1310_23561, RNA1509_26566, RNA1509_29335} {RNA1509_26566, RNA1509_29335, RNA815_9840} |
| 24. | MligTC455_21419 | 43 | 0.9 | Mlig455_003921 | Neo: - |
GIMAP4 | 1.69 | - | - | 0.983 | - | 0.707 | - | Mlig455_003921 {REF} {Length: 1606} {Pfam: AIG1 family [PF04548.18, score=120.0]; 50S ribosome-binding GTPase [PF01926.25, score=29.5]; Septin [PF00735.20, score=28.4]; RsgA GTPase [PF03193.18, score=24.6]} {Human: ENSG00000133574, GIMAP4, GTPase, IMAP family member 4, [Score=77.8, Expect=1e-15]; ENSG00000281887, GIMAP1-GIMAP5, GIMAP1-GIMAP5 readthrough, [Score=75.1, Expect=2e-14]} {Mouse: ENSMUSG00000043931, Gimap7, GTPase, IMAP family member 7, [Score=77.4, Expect=6e-16]} {RNA1509_19903} {RNA1310_21201.1} {RNA815_9568.1} |
| 25. | MligTC455_24162 | 48 | 1 | Mlig455_014024 | Neo: - Age: - |
1.686 | - | - | 0.971 | - | - | 0.715 | Mlig455_014024 {REF} {Length: 3118} {RNA1310_27501} {RNA815_14263} | |
| 26. | MligTC455_35163 | 26 | 0.53 | Mlig455_029011 | Neo: Irradiation Age: Up-Down-Up |
1.678 | - | - | 0.971 | 0.707 | - | - | Mlig455_029011 {REF} {Length: 2292} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=55.8]} {Smed: dd_Smed_v6_13661_0_1, dd_Smed_v6_13661_0_1, [Score=77.4, Expect=9e-16]} {RNA1509_53704} {RNA1310_30699.2} {RNA815_9294.1} | |
| 27. | MligTC455_47248 | 12 | 0.24 | Mlig455_024212 | Neo: - Age: - |
1.654 | - | - | 0.951 | - | 0.703 | - | Mlig455_024212 {REF} {Length: 1646} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.5, Expect=2e-16]} {RNA1310_72968} {RNA815_46883} | |
| 28. | MligTC455_09456 | 47 | 0.97 | Mlig455_029993 | Neo: - Age: - Region-enriched R2: 5.041/0.00960 |
0.998 | - | - | 0.998 | - | - | - | Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870} | |
| 29. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
| 30. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
| 31. | MligTC455_35583 | 48 | 0.99 | Mlig455_009953 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_009953 {REF} {Length: 919} {Pfam: Lectin C-type domain [PF00059.23, score=25.9]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=61.6, Expect=2e-11]} {RNA1509_20946} {RNA1310_71370} {RNA815_4785.4} | |
| 32. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
| 33. | MligTC455_43434 | 12 | 0.25 | Mlig455_049038 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_049038 {REF} {Length: 3155} {Pfam: Peptidase family M13 [PF05649.15, score=24.5]} | |
| 34. | MligTC455_44922 | 15 | 0.31 | Mlig455_040611 | Neo: - Age: - |
AC254952.1 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_040611 {REF} {Length: 1658} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=86.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=85.3]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=1e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=147, Expect=9e-39]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=129, Expect=1e-32]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=136, Expect=2e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=136, Expect=2e-35]} {RNA1310_45581} {RNA815_21574} |
| 35. | MligTC455_47877 | 27 | 0.57 | Mlig455_016941 | Neo: - Age: - |
TRAF4 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_016941 {REF} {Length: 5966} {TRANSSPLICED} {Pfam: TRAF-type zinc finger [PF02176.20, score=84.5]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.6]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=25.2]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=24.2]; zinc finger of C3HC4-type, RING [PF15227.8, score=22.0]; Seven in absentia protein family [PF03145.18, score=21.6]; Ring finger domain [PF13639.8, score=19.3]; zf-RING of BARD1-type protein [PF14835.8, score=19.3]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [RH, Score=240, Expect=1e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [RH, Score=244, Expect=2e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [RH, Score=172, Expect=2e-47]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=262, Expect=1e-81]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_10917} {RNA815_7389} |
| 36. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
| 37. | MligTC455_50704 | 36 | 0.74 | Mlig455_007321, Mlig455_068329 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_007321 {REF} {Length: 1784} {RNA815_63232} Mlig455_068329 {REF} {Length: 1748} {RNA815_63232} |
|
| 38. | MligTC455_03207 | 4 | 0.08 | Mlig455_015436 | Neo: - Age: - |
TANC1 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_015436 {REF} {Length: 1419} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=94.1]; Ankyrin repeats (many copies) [PF13637.8, score=69.0]; Ankyrin repeat [PF13606.8, score=67.3]; Ankyrin repeats (many copies) [PF13857.8, score=61.9]; Ankyrin repeat [PF00023.32, score=48.1]} {Human: ENSG00000115183, TANC1, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1, [Score=80.5, Expect=9e-17]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=79.3, Expect=2e-16]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=78.2, Expect=4e-16]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=77.4, Expect=8e-16]; ENSG00000148677, ANKRD1, ankyrin repeat domain 1, [Score=76.6, Expect=6e-16]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=77.4, Expect=7e-16]; ENSMUSG00000035168, Tanc1, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1, [Score=77.4, Expect=7e-16]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=76.3, Expect=1e-15]; ENSMUSG00000024803, Ankrd1, ankyrin repeat domain 1 (cardiac muscle), [Score=74.3, Expect=3e-15]; ENSMUSG00000066800, Rnasel, ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent), [Score=74.3, Expect=6e-15]; ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=73.9, Expect=9e-15]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=75.1, Expect=3e-15]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=61.2, Expect=9e-11]} {Smed: dd_Smed_v6_1426_0_1, dd_Smed_v6_1426_0_1, [Score=74.3, Expect=2e-15]} {RNA1509_45399} {RNA1310_89867} |
| 39. | MligTC455_09499 | 6 | 0.13 | Mlig455_023388 | Neo: - Age: - |
CALM2 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_023388 {REF} {Length: 759} {Pfam: EF-hand domain pair [PF13499.8, score=93.5]; EF hand [PF00036.34, score=91.3]; EF-hand domain [PF13405.8, score=83.4]; EF hand [PF13202.8, score=70.7]; EF-hand domain pair [PF13833.8, score=65.0]; EF-hand domain [PF14658.8, score=46.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=33.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.0]; EF-hand domain [PF08976.13, score=25.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=124, Expect=1e-35]; ENSG00000160014, CALM3, calmodulin 3, [Score=123, Expect=6e-36]; ENSG00000198668, CALM1, calmodulin 1, [Score=123, Expect=6e-36]; ENSG00000178363, CALML3, calmodulin like 3, [Score=119, Expect=2e-34]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=124, Expect=5e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=123, Expect=4e-36]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=123, Expect=4e-36]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=118, Expect=3e-34]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=125, Expect=5e-37]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=125, Expect=4e-37]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [RH, Score=129, Expect=2e-38]} {RNA1310_67330} |
| 40. | MligTC455_10788 | 3 | 0.06 | Mlig455_067751 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_067751 {REF} {Length: 1014} {Pfam: WSC domain [PF01822.21, score=48.9]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=47.8, Expect=7e-06]} | |
| 41. | MligTC455_12444 | 17 | 0.35 | Mlig455_041806 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_041806 {REF} {Length: 1758} {RNA1310_51055} | |
| 42. | MligTC455_14056 | 14 | 0.28 | Mlig455_049377, Mlig455_062290 | Neo: - Age: - |
ARL4C | 0.996 | - | - | 0.996 | - | - | - | Mlig455_049377 {REF} {Length: 1814} {Pfam: ADP-ribosylation factor family [PF00025.23, score=101.7]; Signal recognition particle receptor beta subunit [PF09439.12, score=36.7]; G-protein alpha subunit [PF00503.22, score=22.3]; 50S ribosome-binding GTPase [PF01926.25, score=21.9]} {Human: ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=95.1, Expect=9e-24]} {Mouse: ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=95.1, Expect=6e-24]; ENSMUSG00000034936, Arl4d, ADP-ribosylation factor-like 4D, [Score=92.8, Expect=5e-23]} {Dmel: FBgn0010348, Arf79F, ADP ribosylation factor at 79F, [Score=80.5, Expect=1e-18]} {Celegans: WBGene00000182, arf-1.2, ADP-ribosylation factor 1-like 2, [Score=81.3, Expect=5e-19]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=101, Expect=9e-27]} {RNA1310_52038} {RNA815_22575.1} Mlig455_062290 {REF} {Length: 1507} {Pfam: ADP-ribosylation factor family [PF00025.23, score=101.7]; Signal recognition particle receptor beta subunit [PF09439.12, score=36.7]; G-protein alpha subunit [PF00503.22, score=22.3]; 50S ribosome-binding GTPase [PF01926.25, score=21.9]} {Human: ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=95.1, Expect=9e-24]} {Mouse: ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=95.1, Expect=6e-24]; ENSMUSG00000034936, Arl4d, ADP-ribosylation factor-like 4D, [Score=92.8, Expect=5e-23]} {Dmel: FBgn0010348, Arf79F, ADP ribosylation factor at 79F, [Score=80.5, Expect=1e-18]} {Celegans: WBGene00000182, arf-1.2, ADP-ribosylation factor 1-like 2, [Score=81.3, Expect=5e-19]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=101, Expect=9e-27]} {RNA1310_52038} {RNA815_22575.1} |
| 43. | MligTC455_14329 | 326 | 6.78 | Mlig455_038755 | Neo: - Age: logFC(26M/2M)=2.873 |
CYP2U1 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_038755 {REF} {Length: 2107} {Pfam: Cytochrome P450 [PF00067.24, score=302.2]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=211, Expect=2e-61]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=204, Expect=2e-59]; ENSG00000138115, CYP2C8, cytochrome P450 family 2 subfamily C member 8, [Score=202, Expect=1e-58]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=213, Expect=1e-62]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=213, Expect=9e-63]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=209, Expect=7e-61]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=209, Expect=7e-61]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=208, Expect=8e-61]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=204, Expect=1e-59]; ENSMUSG00000025002, Cyp2c55, cytochrome P450, family 2, subfamily c, polypeptide 55, [Score=204, Expect=1e-59]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=176, Expect=9e-49]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=1e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=230, Expect=2e-69]} {RNA1509_33783} {RNA1310_2911.1, RNA1509_33783} {RNA1509_33783, RNA815_12179} |
| 44. | MligTC455_14597 | 7 | 0.15 | Mlig455_017638 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_017638 {REF} {Length: 1035} {RNA1310_39570} {RNA815_52309} | |
| 45. | MligTC455_14998 | 33 | 0.69 | Mlig455_066732, Mlig455_066746 | Neo: - Age: Up-Down-Up |
0.996 | - | - | 0.996 | - | - | - | Mlig455_066732 {REF} {Length: 1164} {NoTransDecoderORF} {RNA1509_15876} {RNA1310_16589} {RNA815_40076.1} Mlig455_066746 {REF} {Length: 993} {NoTransDecoderORF} {RNA1509_15876} {RNA1310_16589} {RNA815_40076.1} |
|
| 46. | MligTC455_16437 | 38 | 0.79 | Mlig455_025875 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_025875 {REF} {Length: 1498} {RNA1310_46570} {RNA815_39675} | |
| 47. | MligTC455_16953 | 6 | 0.13 | Mlig455_001340 | Neo: - Age: Down-Up-Up |
0.996 | - | - | 0.996 | - | - | - | Mlig455_001340 {REF} {Length: 2720} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [RH, Score=67.0, Expect=3e-14]} {RNA1310_46281} {RNA815_28578} | |
| 48. | MligTC455_19296 | 22 | 0.46 | Mlig455_007502 | Neo: - Age: - |
IRX4 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_007502 {REF} {Length: 1626} {Pfam: Homeobox KN domain [PF05920.13, score=54.1]; Homeodomain [PF00046.31, score=30.5]} {Human: ENSG00000113430, IRX4, iroquois homeobox 4, [RH, Score=149, Expect=1e-39]; ENSG00000159387, IRX6, iroquois homeobox 6, [RH, Score=145, Expect=1e-38]} {Mouse: ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [RH, Score=150, Expect=7e-40]} {Dmel: FBgn0015919, caup, caupolican, [RH, Score=153, Expect=2e-40]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [RH, Score=124, Expect=7e-32]} {Smed: dd_Smed_v6_18125_0_1, dd_Smed_v6_18125_0_1, [RH, Score=159, Expect=3e-44]} {RNA1310_58105} {RNA815_61910} |
| 49. | MligTC455_19297 | 22 | 0.45 | Mlig455_007400 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_007400 {REF} {Length: 228} {NoTransDecoderORF} | |
| 50. | MligTC455_24669 | 17 | 0.35 | Mlig455_048025 | Neo: - Age: Down-Up-Down |
0.996 | - | - | 0.996 | - | - | - | Mlig455_048025 {REF} {Length: 1594} {RNA1509_48973} {RNA1310_37544} {RNA815_31898} | |
| 51. | MligTC455_29085 | 34 | 0.72 | Mlig455_047082 | Neo: - Age: - |
RASGRF2 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_047082 {REF} {Length: 6322} {Pfam: RasGEF domain [PF00617.21, score=194.4]; RhoGEF domain [PF00621.22, score=120.6]; RasGEF N-terminal motif [PF00618.22, score=68.8]; PH domain [PF00169.31, score=20.4]} {Human: ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [Score=570, Expect=0.0]; ENSG00000058335, RASGRF1, Ras protein specific guanine nucleotide releasing factor 1, [Score=566, Expect=3e-178]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [Score=565, Expect=5e-178]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=167, Expect=4e-41]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=119, Expect=1e-26]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [Score=815, Expect=0.0]} {RNA1509_15697, RNA1509_53969} {RNA1310_2543.1, RNA1509_53969} {RNA1509_53969, RNA815_8228.1} |
| 52. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
0.996 | - | - | 0.996 | - | - | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
| 53. | MligTC455_31403 | 47 | 0.97 | Mlig455_068068 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_068068 {REF} {Length: 6883} {Pfam: Phosphatidylglycerol lysyltransferase, C-terminal [PF09924.11, score=49.1]; Copper binding proteins, plastocyanin/azurin family [PF00127.22, score=37.7]; Four helical bundle domain [PF17947.3, score=29.9]} {RNA1509_15303} {RNA1310_7925.2} {RNA815_2463.1} | |
| 54. | MligTC455_32025 | 18 | 0.36 | Mlig455_028181, Mlig455_028252 | Neo: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_028181 {REF} {Length: 4403} {Pfam: PH domain [PF00169.31, score=19.7]} {RNA1310_106355} Mlig455_028252 {REF} {Length: 3659} {Pfam: PH domain [PF00169.31, score=20.0]} {RNA1310_106355} |
|
| 55. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
| 56. | MligTC455_37305 | 39 | 0.81 | Mlig455_029478 | Neo: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_029478 {REF} {Length: 3097} {Smed: dd_Smed_v6_9825_0_1, dd_Smed_v6_9825_0_1, [Score=53.9, Expect=2e-07]} {RNA1509_42508, RNA1509_53631} {RNA1310_33865.1, RNA1509_42508, RNA1509_53631} {RNA1509_42508, RNA1509_53631, RNA815_36519} | |
| 57. | MligTC455_39711 | 271 | 5.64 | Mlig455_049786 | Neo: - Age: logFC(26M/2M)=-0.442 Region-enriched R5: 3.339/0.00007 Regeneration-downregulated R5: -6.137 Regeneration-depleted R5: -6.137 |
XDH | 0.996 | - | - | 0.996 | - | - | - | Mlig455_049786 {REF} {Length: 5802} {Pfam: Molybdopterin-binding domain of aldehyde dehydrogenase [PF02738.20, score=421.5]; Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain [PF01315.24, score=76.8]; CO dehydrogenase flavoprotein C-terminal domain [PF03450.19, score=70.0]; FAD binding domain in molybdopterin dehydrogenase [PF00941.23, score=41.6]} {Human: ENSG00000158125, XDH, xanthine dehydrogenase, [Score=367, Expect=8e-108]; ENSG00000138356, AOX1, aldehyde oxidase 1, [Score=357, Expect=3e-104]} {Mouse: ENSMUSG00000024066, Xdh, xanthine dehydrogenase, [Score=376, Expect=3e-111]} {Dmel: FBgn0267408, AOX1, Aldehyde oxidase 1, [Score=536, Expect=6e-171]} {Celegans: WBGene00010083, xhd-1, [Score=373, Expect=3e-110]} {RNA1509_4282} {RNA1310_1564.1} {RNA815_637} |
| 58. | MligTC455_42590 | 32 | 0.67 | Mlig455_050244 | Neo: - Age: - |
GALR2 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_050244 {REF} {Length: 1946} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=40.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.4]; Olfactory receptor [PF13853.8, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=20.6]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=164, Expect=4e-46]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=160, Expect=6e-45]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [RH, Score=216, Expect=6e-66]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [RH, Score=208, Expect=1e-62]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=282, Expect=6e-91]} {RNA1310_75607} {RNA815_49665} |
| 59. | MligTC455_42663 | 15 | 0.32 | Mlig455_037730 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_037730 {REF} {Length: 250} {NoTransDecoderORF} {RNA1310_96594} | |
| 60. | MligTC455_51091 | 19 | 0.39 | Mlig455_056866 | Neo: - Age: - |
TTN | 0.996 | - | - | 0.996 | - | - | - | Mlig455_056866 {REF} {Length: 2785} {Pfam: Immunoglobulin domain [PF13927.8, score=55.3]; Immunoglobulin I-set domain [PF07679.18, score=54.2]; Immunoglobulin domain [PF00047.27, score=42.7]; Immunoglobulin domain [PF13895.8, score=41.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=23.2]} {Human: ENSG00000155657, TTN, titin, [Score=58.9, Expect=2e-08]; ENSG00000163531, NFASC, neurofascin, [Score=57.0, Expect=5e-08]} {Mouse: ENSMUSG00000026442, Nfasc, neurofascin, [Score=56.6, Expect=7e-08]; ENSMUSG00000051747, Ttn, titin, [Score=56.2, Expect=9e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.8, Expect=1e-07]} {Dmel: FBgn0003984, vn, vein, [Score=58.9, Expect=8e-09]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=50.1, Expect=4e-06]} {Smed: dd_Smed_v6_15129_0_2, dd_Smed_v6_15129_0_2, [RH, Score=96.7, Expect=2e-21]} {RNA1509_60115} {RNA1310_47926.1} {RNA815_39809} |
| 61. | MligTC455_26690 | 58 | 1.2 | Mlig455_044790 | Neo: - Age: - |
PDE9A | 0.995 | - | - | 0.995 | - | - | - | Mlig455_044790 {REF} {Length: 2883} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.3]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=605, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=353, Expect=3e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=186, Expect=5e-52]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=6e-106]} {RNA1310_14017} {RNA815_23817} |
| 62. | MligTC455_49094 | 59 | 1.22 | Mlig455_065396 | Neo: - Age: - |
RERGL | 0.995 | - | - | 0.995 | - | - | - | Mlig455_065396 {REF} {Length: 1449} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=61.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=25.4]} {Human: ENSG00000111404, RERGL, RERG like, [Score=80.5, Expect=7e-18]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=80.1, Expect=7e-18]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=84.7, Expect=1e-19]} {Dmel: FBgn0035711, CG8519, [Score=69.3, Expect=4e-14]} {Celegans: WBGene00004309, rap-3, RAP homolog (Vertebrate Rap GTPase family), [Score=59.3, Expect=1e-10]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=80.1, Expect=3e-18]} {RNA1509_41924} {RNA1310_34154} {RNA815_43516} |
| 63. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
0.995 | - | - | 0.995 | - | - | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
| 64. | MligTC455_09423 | 8 | 0.16 | Mlig455_012197 | Neo: - Age: - |
0.994 | - | - | 0.994 | - | - | - | Mlig455_012197 {REF} {Length: 327} {NoTransDecoderORF} {RNA1310_92544} | |
| 65. | MligTC455_15974 | 179 | 3.73 | Mlig455_046153, Mlig455_046238 | Neo: - Age: - Region-enriched R2: 9.367/0.02495 |
0.994 | - | - | 0.994 | - | - | - | Mlig455_046153 {REF} {Length: 345} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.0]} {RNA1310_79109} {RNA815_46493} Mlig455_046238 {REF} {Length: 211} {NoTransDecoderORF} {RNA1310_79109} {RNA815_46493} |
|
| 66. | MligTC455_31370 | 27 | 0.55 | Mlig455_035805 | Neo: - Age: - |
ASIC1 | 0.994 | - | - | 0.994 | - | - | - | Mlig455_035805 {REF} {Length: 3035} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.1, Expect=8e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=107, Expect=3e-24]} {RNA1310_49983} {RNA815_25991} |
| 67. | MligTC455_32312 | 65 | 1.36 | Mlig455_026936, Mlig455_027086 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.552/0.00000 |
0.994 | - | - | 0.994 | - | - | - | Mlig455_026936 {REF} {Length: 1813} {Pfam: PAN domain [PF00024.28, score=22.0]} {RNA1310_30037.2} {RNA815_37290} Mlig455_027086 {REF} {Length: 7697} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1509_4722} {RNA1310_655.1} {RNA815_786} |
|
| 68. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
0.993 | - | - | 0.993 | - | - | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 69. | MligTC455_17932 | 22 | 0.45 | Mlig455_002921, Mlig455_002939 | Neo: - Age: - |
KCP | 0.993 | - | - | 0.993 | - | - | - | Mlig455_002921 {REF} {Length: 969} {Pfam: von Willebrand factor type C domain [PF00093.20, score=44.3]; EGF domain [PF12947.9, score=28.3]; MSP1 EGF domain 1 [PF12946.9, score=18.9]} {Human: ENSG00000135253, KCP, kielin/chordin-like protein, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00008952, F19C6.3, [Score=51.2, Expect=1e-06]} {Smed: dd_Smed_v6_11653_0_1, dd_Smed_v6_11653_0_1, [Score=58.5, Expect=5e-09]} {RNA1310_81278} Mlig455_002939 {REF} {Length: 884} {Pfam: von Willebrand factor type C domain [PF00093.20, score=44.7]; EGF domain [PF12947.9, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=20.4]} {Human: ENSG00000135253, KCP, kielin/chordin-like protein, [Score=55.5, Expect=1e-07]} {Mouse: ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=57.8, Expect=2e-08]} {Celegans: WBGene00008952, F19C6.3, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_11653_0_1, dd_Smed_v6_11653_0_1, [Score=51.6, Expect=5e-07]} {RNA1310_81278} |
| 70. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
0.993 | - | - | 0.993 | - | - | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
| 71. | MligTC455_23287 | 106 | 2.21 | Mlig455_052789 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.273/0.00029 |
0.993 | - | - | 0.993 | - | - | - | Mlig455_052789 {REF} {Length: 2348} {RNA1310_41474} {RNA815_41242} | |
| 72. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
0.993 | - | - | 0.993 | - | - | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
| 73. | MligTC455_40226 | 43 | 0.89 | Mlig455_010646, Mlig455_010651 | Neo: - Age: - |
GRIK2 | 0.993 | - | - | 0.993 | - | - | - | Mlig455_010646 {REF} {Length: 1094} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1310_59687} {RNA815_48326} Mlig455_010651 {REF} {Length: 3614} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1509_35609} {RNA1310_6947.1} {RNA815_20684} |
| 74. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 0.992 | - | - | 0.992 | - | - | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
| 75. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 0.992 | - | - | 0.992 | - | - | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
| 76. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 0.992 | - | - | 0.992 | - | - | - | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
| 77. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
0.992 | - | - | 0.992 | - | - | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
| 78. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 0.992 | - | - | 0.992 | - | - | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
| 79. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 0.991 | - | - | 0.991 | - | - | - | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
| 80. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 0.991 | - | - | 0.991 | - | - | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
| 81. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 0.991 | - | - | 0.991 | - | - | - | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
| 82. | MligTC455_49373 | 49 | 1.03 | Mlig455_000061 | Neo: - Age: - |
ECT2 | 0.991 | - | - | 0.991 | - | - | - | Mlig455_000061 {REF} {Length: 2785} {Pfam: RhoGEF domain [PF00621.22, score=121.5]; ZIP Zinc transporter [PF02535.24, score=20.6]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=72.8, Expect=2e-13]} {Mouse: ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=72.8, Expect=1e-13]} {Dmel: FBgn0262562, CG43102, [Score=77.4, Expect=3e-15]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=58.9, Expect=2e-09]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=52.8, Expect=2e-07]} {RNA1509_60002} {RNA1310_20791, RNA1509_60002} {RNA1509_60002, RNA815_13312} |
| 83. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
0.991 | - | - | 0.991 | - | - | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
| 84. | MligTC455_07323 | 40 | 0.82 | Mlig455_015074, Mlig455_015193 | Neo: - Age: - |
0.99 | - | - | 0.990 | - | - | - | Mlig455_015074 {REF} {Length: 4015} {Pfam: Initiation control protein YabA [PF06156.15, score=24.3]} {RNA1509_58516} {RNA1310_40818} {RNA815_42071} Mlig455_015193 {REF} {Length: 4016} {Pfam: Initiation control protein YabA [PF06156.15, score=24.3]} {RNA1509_58516} {RNA1310_40818} {RNA815_42071} |
|
| 85. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
0.99 | - | - | 0.990 | - | - | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 86. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 0.989 | - | - | 0.989 | - | - | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
| 87. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
0.989 | - | - | 0.989 | - | - | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
| 88. | MligTC455_22213 | 13 | 0.27 | Mlig455_014034 | Neo: - Age: Up-Down-Down |
0.989 | - | - | 0.989 | - | - | - | Mlig455_014034 {REF} {Length: 4980} {Pfam: Lectin C-type domain [PF00059.23, score=19.7]} {RNA1310_27313} {RNA815_43769} | |
| 89. | MligTC455_36964 | 19 | 0.39 | Mlig455_066953 | Neo: - Age: Down-Up-Down |
AVPR1B | 0.989 | - | - | 0.989 | - | - | - | Mlig455_066953 {REF} {Length: 2640} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=151.8]} {Human: ENSG00000198049, AVPR1B, arginine vasopressin receptor 1B, [Score=91.3, Expect=4e-19]} {Mouse: ENSMUSG00000049112, Oxtr, oxytocin receptor, [Score=94.0, Expect=3e-20]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=80.5, Expect=7e-16]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=79.0, Expect=3e-15]} {Smed: dd_Smed_v6_41696_0_1, dd_Smed_v6_41696_0_1, [Score=67.8, Expect=4e-12]} {RNA1310_72444} {RNA815_35126} |
| 90. | MligTC455_45731 | 76 | 1.59 | Mlig455_003947, Mlig455_003964, Mlig455_005981 | Neo: - Age: Up-Down-Down |
TTLL7 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_003947 {REF} {Length: 4060} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=212.9]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=351, Expect=4e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=347, Expect=1e-103]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=3e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=158, Expect=4e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=313, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_003964 {REF} {Length: 3783} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.2]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-109]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=2e-104]} {Dmel: FBgn0039501, CG5987, [Score=234, Expect=4e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=7e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=312, Expect=4e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_005981 {REF} {Length: 4222} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.3]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.7]; YheC/D like ATP-grasp [PF14398.8, score=21.1]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=9e-104]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=5e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=9e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=314, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} |
| 91. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |
| 92. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
0.989 | - | - | 0.989 | - | - | - | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
| 93. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 0.988 | - | - | 0.988 | - | - | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
| 94. | MligTC455_14171 | 4 | 0.09 | Mlig455_068710 | Neo: - Age: - |
WSCD2 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_068710 {REF} {Length: 1169} {Pfam: WSC domain [PF01822.21, score=42.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=4e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=3e-06]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=6e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=1e-10]} {RNA1310_39527} {RNA815_19067} |
| 95. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 0.988 | - | - | 0.988 | - | - | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
| 96. | MligTC455_40328 | 26 | 0.54 | Mlig455_054438 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_054438 {REF} {Length: 1987} {NoTransDecoderORF} {RNA1509_27938} {RNA1310_55383} | |
| 97. | MligTC455_51872 | 25 | 0.51 | Mlig455_002762, Mlig455_063364 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_002762 {REF} {Length: 1093} {RNA1310_80259} {RNA815_47710} Mlig455_063364 {REF} {Length: 1091} {RNA1310_80259} {RNA815_47710} |
|
| 98. | MligTC455_17826 | 46 | 0.96 | Mlig455_058007, Mlig455_058200 | Neo: - Age: Up-Down-Down |
0.987 | - | - | 0.987 | - | - | - | Mlig455_058007 {REF} {Length: 2671} {Pfam: Ephrin [PF00812.19, score=47.2]} {Mouse: ENSMUSG00000031217, Efnb1, ephrin B1, [RH, Score=55.8, Expect=1e-08]} {RNA1310_27470} {RNA815_23494} Mlig455_058200 {REF} {Length: 3117} {Pfam: Ephrin [PF00812.19, score=47.1]} {Mouse: ENSMUSG00000031217, Efnb1, ephrin B1, [RH, Score=55.8, Expect=9e-09]} {RNA1310_27470} {RNA815_32142} |
|
| 99. | MligTC455_33705 | 35 | 0.73 | Mlig455_063348 | Neo: - Age: Up-Down-Down |
COL9A2 | 0.987 | - | - | 0.987 | - | - | - | Mlig455_063348 {REF} {Length: 7183} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=100.7]; Myotubularin protein [PF12335.10, score=23.7]} {Human: ENSG00000049089, COL9A2, collagen type IX alpha 2 chain, [Score=112, Expect=8e-25]; ENSG00000204262, COL5A2, collagen type V alpha 2 chain, [Score=111, Expect=4e-24]} {Mouse: ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=119, Expect=1e-26]; ENSMUSG00000045672, Col27a1, collagen, type XXVII, alpha 1, [Score=117, Expect=3e-26]; ENSMUSG00000026147, Col9a1, collagen, type IX, alpha 1, [Score=116, Expect=4e-26]; ENSMUSG00000028626, Col9a2, collagen, type IX, alpha 2, [Score=115, Expect=5e-26]} {Dmel: FBgn0016075, vkg, viking, [Score=106, Expect=7e-23]} {Celegans: WBGene00001263, emb-9, Collagen alpha-1(IV) chain, [Score=80.9, Expect=4e-15]} {Smed: dd_Smed_v6_832_0_1, dd_Smed_v6_832_0_1, [Score=140, Expect=1e-33]} {RNA1310_28728} {RNA815_22052} |
| 100. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
0.987 | - | - | 0.987 | - | - | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} |
There are 312 more genes with r >= 0.95